We are live on ! Find out more
ACM

Argyle Capital Management Portfolio holdings

AUM $347M
1-Year Est. Return 44.33%
This Fund
S&P 500
This Quarter Est. Return
+4.04%
1 Year Est. Return
+44.33%
3 Year Est. Return
+95.77%
5 Year Est. Return
+124.66%
10 Year Est. Return
+325.03%
AUM
$214M
AUM Growth
+$10.8M
Cap. Flow
+$3.35M
Cap. Flow %
1.56%
Top 10 Hldgs %
22.52%
Holding
110
New
2
Increased
6
Reduced
20
Closed

Top Buys

Rank Stock Value
1
MET icon
MetLife
MET
+$2.23M
2
JPM icon
JPMorgan Chase
JPM
+$1.8M
3
GM
GEN MOTORS CORP
GM
+$541K
4
PFE icon
Pfizer
PFE
+$246K
5
IBM icon
IBM
IBM
+$32.9K

Top Sells

Rank Stock Value
1
MCK icon
McKesson
MCK
+$1.17M
2
TWX
Time Warner Inc
TWX
+$79.4K
3
ORCL icon
Oracle
ORCL
+$61.7K
4
MSFT icon
Microsoft
MSFT
+$48.6K
5
BMY icon
Bristol-Myers Squibb
BMY
+$37K

Sector Composition

Rank Sector Weight
1 Healthcare 22.43%
2 Technology 13.97%
3 Energy 13.25%
4 Industrials 11.53%
5 Communication Services 7.44%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MRK icon
1
Merck
MRK
$322B
$5.73M 2.67%
103,875
-326
-0.3% -$17.8K
BMY icon
2
Bristol-Myers Squibb
BMY
$133B
$5.17M 2.41%
106,638
-750
-0.7% -$37K
PFE icon
3
Pfizer
PFE
$143B
$5.17M 2.41%
183,532
+8,643
+5% +$246K
MSFT icon
4
Microsoft
MSFT
$3.45T
$5.1M 2.38%
122,352
-1,200
-1% -$48.6K
AMGN icon
5
Amgen
AMGN
$208B
$4.67M 2.18%
39,449
VZ icon
6
Verizon
VZ
$195B
$4.63M 2.16%
94,524
MMM icon
7
3M
MMM
$90.9B
$4.57M 2.13%
38,185
-30
-0.1% -$3.52K
INTC icon
8
Intel
INTC
$455B
$4.47M 2.08%
144,700
-150
-0.1% -$4.11K
T icon
9
AT&T
T
$159B
$4.41M 2.06%
165,225
IBM icon
10
IBM
IBM
$211B
$4.38M 2.04%
25,257
+183
+0.7% +$32.9K
MCK icon
11
McKesson
MCK
$100B
$4.38M 2.04%
23,500
-6,550
-22% -$1.17M
KO icon
12
Coca-Cola
KO
$377B
$4.24M 1.98%
99,989
-200
-0.2% -$8.12K
COP icon
13
ConocoPhillips
COP
$147B
$4.15M 1.93%
48,369
GPC icon
14
Genuine Parts
GPC
$17.1B
$4.07M 1.9%
46,361
-350
-0.7% -$30.1K
SE
15
DELISTED
Spectra Energy Corp Wi
SE
$4.05M 1.89%
95,449
GE icon
16
GE Aerospace
GE
$374B
$3.97M 1.85%
31,527
JNJ icon
17
Johnson & Johnson
JNJ
$618B
$3.89M 1.81%
37,205
-40
-0.1% -$4.04K
RTN
18
DELISTED
Raytheon Company
RTN
$3.85M 1.79%
41,725
UPS icon
19
United Parcel Service
UPS
$88.6B
$3.81M 1.78%
37,160
-350
-0.9% -$35.1K
MDT icon
20
Medtronic
MDT
$109B
$3.8M 1.77%
59,628
-182
-0.3% -$11.1K
DUK icon
21
Duke Energy
DUK
$97.8B
$3.75M 1.75%
50,556
PAYX icon
22
Paychex
PAYX
$41.6B
$3.58M 1.67%
86,172
PPL
23
PPL Corp
PPL
$26.5B
$3.52M 1.64%
106,533
CVX icon
24
Chevron
CVX
$392B
$3.47M 1.62%
26,571
LLY icon
25
Eli Lilly
LLY
$1.02T
$3.47M 1.62%
55,749

Similar funds

Argyle Capital Management's Q2 2014 Portfolio in Review

As of Q2 2014, Argyle Capital Management held 110 positions worth $214M, up 5.3% from $204M the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Trading was light in Q2 2014: portfolio turnover was 1.8%. Argyle Capital Management opened 2 new positions and made no exits, leaving the 110-position portfolio largely intact.

By sector, the portfolio is most concentrated in Healthcare at 22% of assets, down from 24% a quarter earlier, followed by Technology and Energy.

  • Argyle Capital Management's largest Q2 2014 buy was MetLife: 47,629 shares worth $2.36M.
  • Argyle Capital Management added most to JPMorgan Chase in Q2 2014, an estimated $1.8M increase.
  • Argyle Capital Management's biggest Q2 2014 reduction was McKesson, cutting an estimated $1.17M.
  • Argyle Capital Management's ten largest holdings make up 23% of its $214M portfolio in Q2 2014.
  • Argyle Capital Management opened 2 new positions and closed 0 in Q2 2014.
  • Argyle Capital Management's portfolio value rose 5.3% quarter-over-quarter to $214M.

Based on Argyle Capital Management's 13F filing for Q2 2014, filed 25 Jul 2014.